Chatain et al. elucidated that FLT3 JMD point mutations and deletions in AML led to phosphorylation of both STAT3 and STAT5, while FLT3-ITD mainly activated STAT5 over STAT3 [35]. This evidence concerns the gene STAT3 and acute myeloid leukemia.